The name has been changed with effect from December 29, 2021

Amradeep Industries renames as ‘Amerise Biosciences’

Amradeep Industries reports standalone net profit of Rs 0.30 crore in the June 2021 quarter

Hasn't fared well - amongst the low performers

Seems to be overvalued vs the market average

Lagging behind the market in financials growth

Profitability and efficiency haven't been upto the mark

Good time to consider, stock is not in the overbought zone

The stock has a moderate number of red flags

Amerise Biosciences Ltd is currently inactive and did not generate any revenue.

With a market cap of ₹7 cr, stock is ranked 4,574